Long-Term Treatment with Olaparib May Help Treat Recurrent Ovarian Cancer
This PARP inhibitor is effective in extending the progression-free survival of recurrent patients with an inherited version of a DNA deficiency as well as a non-inherited version. Interesting study. I can't wait to hear more about olaparib. Here is a Med-Page link that explains the study further.
Screening Does Not Reduce Deaths from Ovarian Cancer for the General Population
This large ( 80,000 particpant) study highlights the need for further research to find a a screening test for the general public for ovarian cancer. CA-125 and Ultrasound together to screen for the disease did not reduce mortality numbers.
Dee
Every Day is a Blessing!
No comments:
Post a Comment